MedTrace Logo

Diclofenac Potassium Alone Versus Diclofenac Potassium With Hyoscine-N-butyl Bromide (HBB in Endoscopy

NCT04125771 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2021-11-02

No results posted yet for this study

Summary

Diclofenac is a proven, commonly prescribed nonsteroidal anti-inflammatory drug (NSAID) that has analgesic, anti-inflammatory, and antipyretic properties, and has been shown to be effective in treating a variety of acute and chronic pain and inflammatory conditions.

Conditions

Interventions

DIAGNOSTIC_TEST

Diclofenac + HBB with hysteroscopy

Giving Diclofenac + HBB with hysteroscopy

DIAGNOSTIC_TEST

Diclofenav + placebo

Giving Diclofenac + placebo with hysteroscopy

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy, PhD · Algezeera hospitaland National Research Centre ,Egypt

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-16
Primary Completion
2020-08-25
Completion
2020-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04125771 on ClinicalTrials.gov